Lofton Kevin E 4
4 · GILEAD SCIENCES, INC. · Filed May 4, 2023
Insider Transaction Report
Form 4
Lofton Kevin E
Director
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2023-05-03$79.45/sh+10,173$808,245→ 10,173 totalExercise: $79.45Exp: 2033-05-03→ Common Stock (10,173 underlying) - Award
Common Stock
2023-05-03+1,887→ 92,653 total(indirect: By Trust)
Footnotes (3)
- [F1]Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023.
- [F2]Shares are held in a Revocable Living Trust.
- [F3]100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023.